In our breast cancer patient cohort, we observed reduced HTRA1 expression levels particularly in patients exhibiting unfavorable clinical features such as high numbers of affected lymph nodes (≥4 lymph nodes; see Table 1). The gene discussed is HTRA1; the disease is breast carcinoma.